FindTrial
Sign In

BOLD-100

DRUG2 trials

Sponsors

Bold Therapeutics Inc., University Health Network, Toronto

Conditions

Advanced Solid Gastrointestinal TumorsCholangiocarcinomaColorectal CancerGastric CancerPancreatic CancerSarcomaSarcoma, Soft-tissueSarcoma,Soft Tissue

Phase 1

A Phase 1b/2a Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid Tumours
RecruitingCTIS2024-517500-11-00
Bold Therapeutics Inc.Advanced Solid Gastrointestinal Tumors, Cholangiocarcinoma, Colorectal Cancer +2
Start: 2025-07-15Target: 10Updated: 2025-10-30
BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
Not yet recruitingNCT07027423
University Health Network, TorontoSarcoma, Sarcomas, Sarcoma, Soft-tissue +1
Start: 2026-03-30End: 2027-01-29Target: 32Updated: 2025-12-01